Litcius/Paper detail

Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.

Agathe Bonnaire, Véronique Vernet-Garnier, Delphine Lebrun, Odile Bajolet, Morgane Bonnet, Maxime Hentzien, Xavier Ohl, Saïdou Diallo, Firouzé Bani‐Sadr

2020Diagnostic Microbiology and Infectious Disease24 citationsDOIOpen Access PDF

Topics & Concepts

ClindamycinErythromycinLincosamidesMedicineAntibioticsOsteomyelitisStaphylococcus aureusStaphylococcusSurgeryInternal medicineMicrobiologyBiologyBacteriaGeneticsOrthopedic Infections and TreatmentsAntimicrobial Resistance in StaphylococcusInfectious Diseases and Tuberculosis
Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp. | Litcius